Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
Samuel V RasmussenAgnieszka WozniakMelvin LatharaJoshua M GoldenbergBenjamin M SamudioLissett R BickfordKiyo NagamoriHollis WrightAndrew D WoodsShefali ChauhanChe-Jui LeeErin R RudzinskiMichael K SwiftTadashi KondoDavid E FisherEvgeny ImyanitovIsidro MachadoAntonio Llombart-BoschIrene L AndrulisNalan GokgozJay WunderHiroshi MirotakiTakuro NakamuraGanapati SrinivasaKhin ThwayRobin L JonesPaul H HuangNoah E BerlowPatrick SchöffskiCharles KellerPublished in: British journal of cancer (2023)
These studies of the genomic, transcriptomic and chemical biology landscape represent a resource 'atlas' for the field of CCS investigation and drug development. CHK inhibitors are identified as having potential relevance, CREB1 inhibitors non-dependence of CCS on CREB1 activity was established, and the potential utility of HER3 ADC being used in CCS is found.